Trinity Biotech plc (Nasdaq: TRIB), a commercial-stage biotechnology company focused on human diagnostics and diabetes management solutions, including wearable biosensors, today unveiled its new ...

GlucoModicum Reports Positive Clinical Results with its Needle-Free CGM and Advances Toward Market Launch Comprehensive clinical performance study encompassed 646 participant visits, including ...

Participants in the study used GlucoModicum's next-generation, needle-free CGM across both standard multi-hour glucose tolerance tests and ambulatory conditions involving exercise and meals.

GlucoModicum Reports Positive Clinical Results with its Needle-Free CGM and Advances Toward Market Launch Comprehensive clinical performance study encompassed 646 participant visits, including both ...

Helsinki, Finland – July 2, 2025 — GlucoModicum, a health technology innovator focused on needle-free glucose monitoring, today announced positive results from its Clinical Performance Study ...

OSR Holdings signs term sheet to acquire South Korea-based noninvasive glucose monitoring technology company, Woori IO: Bellevue, Washington Friday, July 25, 2025, 14:00 Hrs [IST] ...

Trinity Biotech (Nasdaq:TRIB) announced today that it unveiled its new flagship continuous glucose monitor (CGM) biosensor ...

THIRUVANANTHAPURAM: The three-day international diabetes conference, Jothydev’s Professional Education Forum Diabetes Update 2025 (JPEF 2025), came to a close i ...